Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclophosphamide hemorrhagic cystitis requiring urinary diversion

A L Golin, R C Benson

    The Journal of Urology
    |July 1, 1977
    PubMed
    Summary

    Cyclophosphamide can cause hemorrhagic cystitis, a serious bladder complication. While often manageable, severe cases may require advanced treatments like urinary diversion.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Gynecologic examination.

    Pediatric annals·2014
    Same author

    The treatment of acute postpartum thrombophlebitis of the lower extremity by continuous caudal anesthesia.

    American journal of obstetrics and gynecology·2010
    Same author

    Minimal spinal anesthesia in vaginal delivery; an analysis of 1,000 consecutive cases.

    American journal of obstetrics and gynecology·2010
    Same author

    An automated, handheld biosensor for aflatoxin.

    Biosensors & bioelectronics·2000
    Same author

    Centering mechanism for soft contact lenses.

    Journal of biomechanical engineering·1999
    Same author

    A microplate allele-specific oligonucleotide hybridization assay for detection of factor V Leiden.

    Diagnostic molecular pathology : the American journal of surgical pathology, part B·1998

    Area of Science:

    • Urology
    • Oncology
    • Pharmacology

    Background:

    • Cyclophosphamide is a widely used chemotherapy agent.
    • Hemorrhagic cystitis is a recognized urologic complication of cyclophosphamide treatment.
    • This condition presents unique challenges in patient management.

    Observation:

    • Hemorrhagic cystitis involves bladder bleeding caused by cyclophosphamide.
    • Most cases resolve with drug cessation and supportive care.
    • Refractory cases pose significant treatment difficulties and potential life threats.

    Findings:

    • The pathology of cyclophosphamide-induced hemorrhagic cystitis is reviewed.
    • Treatment strategies for this condition are discussed.
    • A case requiring urinary diversion for refractory disease is highlighted.

    Implications:

    • Understanding cyclophosphamide's urologic toxicity is crucial for oncologists and urologists.
    • Early recognition and management of hemorrhagic cystitis can prevent severe outcomes.
    • Urinary diversion represents a critical option for life-threatening, refractory cases.

    Related Experiment Videos